Although the IgG4 autoantibodies are pathogenic in both the TTP and PF patients and animal models, the IgG4 subclass can attenuate the pathogenic function of anti-ADAMTS13 autoantibodies when the otherwise more pathogenic IgG1 subclass is considered. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.